Site Sponsors
  • Strem Chemicals - Nanomaterials for R&D
  • Park Systems - Manufacturer of a complete range of AFM solutions
  • Oxford Instruments Nanoanalysis - X-Max Large Area Analytical EDS SDD

Search

Request for Quote (RFQ): If you'd like us to help you source a Quotation for any particular products or from any suppliers, please click here. Once submitted, we will try and place you in contact with a suitable supplier within 48 hours.
Search is Loading...
Results 1 - 10 of 13 for DNT.
Search
  • US-based Dendritic Nanotechnologies Inc (DNT) a subsidiary of Starpharma Holdings, holds rights to a large body of dendrimer and dendritic polymer related IP. Dendritic NanoTechnologies is...
  • The National Dendrimer & Nanotechnology Center serves as a model of collaboration, leveraging the combined academic, government and private sector research expertise of it founding partners....
  • University of California, Berkeley chemists have used silver nanowires as key elements of a sensitive explosives detector. Posted September 11 2003
  • Oncologix Tech Inc. announced today that it has qualified a new design of its Oncosphere product in response to the "leaching" problem found in its previous design. The improved design was...
  • Starpharma today announced that its wholly owned subsidiary Dendritic Nanotechnologies Inc (DNT) will develop its proprietary technology to purify water following the award of a contract with...
  • As dendrimers offer manufacturers the prospect of making vast profits in a number of different industry areas, the race to register patents for dendrimers has been fierce. The story of how Dendritic...
  • Starpharma Holdings Limited (ASX:SPL, OTCQX:SPHRY) today announced the signing of a research and collaboration agreement between its wholly owned US subsidiary, DNT Inc, and a prominent,...
  • Starpharma Holdings Ltd today announced the first commercial product launch based on its Priostar® dendrimer technology. The product, a research reagent kit called...
  • Starpharma Holdings Limited (ASX:SPL, OTCQX:SPHRY) and the Monash Institute of Pharmaceutical Sciences (MIPS) have been awarded an Australian Research Council funding grant for the purpose...
  • Starpharma Holdings Limited (ASX:SPL, OTCQX:SPHRY) today announced that it has received notification of the grant in the US of a key patent specifically relating to the use of SPL7013 to...
Result Page 12